A newly developed compound that reduces harmful inflammation in rats caused by overactive neutrophils shows great potential as a safer treatment for various inflammatory diseases in humans.

A newly developed compound that reduces harmful inflammation in rats caused by overactive neutrophils shows great potential as a safer treatment for various inflammatory diseases in humans.

Neutrolis Inc., a clinical-stage biotech company focused on targeting Neutrophil Extracellular Traps (NETs) to revolutionize ...

Neutrophils play a crucial role by engulfing pathogens and releasing enzymes that kill invaders to fight infections. When they are activated by infection, neutrophils can release neutrophil ...

Intracerebral hemorrhages (ICH) account for 15% of strokes but a disproportionate 50% of all stroke deaths. An ICH occurs ...

New research maps how bone marrow changes in acute myeloid leukemia disrupt neutrophil development and boost the risk for ...

This scanning electron microscopy image captures the moment where degranulating mast cells (pseudo-colored in sepia) attract and start to incorporate living neutrophils (pseudo-colored in cyan), ...

People with Sweet's syndrome often wake up with a fever, body aches, and blisters on their neck, limbs and face. Also known ...

In a recent study published in Nature Communications, researchers explored neutrophil involvement in visceral adipose tissue (VAT) inflammation in obesity. Study ...

Known for their role in allergic reactions, mast cells have long been recognised as key players in our immune system. When they encounter allergens, they release chemicals that trigger typical allergy ...